Genus at a glance
| Field | Detail |
|---|---|
| Classification | Genus |
| Family | Hymenogastraceae |
| Described species | Around 150 to 200, with roughly half producing psilocybin |
| Spore print | Dark purple-brown to purple-black |
| Distribution | Cosmopolitan, present on every continent except Antarctica |
| Habitat | Dung, wood debris, rich soil, grassland, and mossy ground |
| Key alkaloids | Psilocybin, psilocin, baeocystin, norbaeocystin, aeruginascin |
Overview
Psilocybe is the genus most people mean when they say "magic mushroom," even when they do not know the name. It holds the species that appear in the clinical trials, the ceremonies, the field guides, and the legal debates, and it is the reference point against which every other psilocybin producer is measured. Where other genera carry psilocybin as a rare exception, Psilocybe carries it as a defining trait: a large share of its species produce the compound, and several do so at concentrations high enough to have shaped human culture for thousands of years.
The genus is saprotrophic, meaning it feeds on dead organic matter rather than partnering with living tree roots. That lifestyle explains where these mushrooms turn up. They colonise cattle and horse dung, decaying hardwood chips and mulch, the thatch of old pastures, and the rich soil of disturbed ground. This preference for human-shaped landscapes, grazed fields, wood-chipped gardens, roadside verges, is part of why Psilocybe species have spread so widely and why they keep appearing in new places as people move mulch and livestock around the world.
A practical marker runs through the genus. Most active Psilocybe bruise blue or blue-green where they are handled or damaged, a reaction caused by the oxidation of psilocin. The bluing is not a reliable identification tool on its own, because it varies and because a few unrelated fungi also discolour, but it is one of the traits that first drew chemists to the group and remains a recognisable signature of the genus in the field.
Documented species
| Species | Notes | Distribution |
|---|---|---|
| P. cubensis | The most widely known and cultivated species; large, dung-loving, easy to grow | Pantropical and subtropical |
| P. semilanceata | The "liberty cap"; small, potent, grassland species of cool climates | Europe, North America |
| P. cyanescens | The "wavy cap"; wood-chip species, notably potent | Temperate, spreading with mulch |
| P. azurescens | Coastal wood-debris species, among the highest recorded potencies | Pacific Northwest |
| P. mexicana | The species tied to Mesoamerican ceremony and to the first laboratory isolation | Mexico, Central America |
| P. cyanofibrillosa | Small wood-associated species | Pacific coast |
Ecology and identification
Psilocybe species are small to medium mushrooms with conical to bell-shaped caps that often become broadly umbonate with age. Cap surfaces are frequently hygrophanous, meaning they change colour markedly as they lose moisture, fading from a darker, water-soaked tone to a paler one as they dry. This single trait causes endless confusion, because the same mushroom can look like two different things over the course of a day.
The gills are attached and darken as the spores mature, ending up a deep purple-brown that matches the spore print. The stems are typically slender and cartilaginous, sometimes with a faint ring zone left by an early partial veil. None of these features is unique on its own, and the genus overlaps in appearance with a long list of small brown mushrooms, some harmless, some toxic. Serious identification depends on spore print colour, microscopy, and habitat taken together, not on any single visual cue.
Because the genus favours dung and disturbed ground, its members often fruit in flushes after rain, appearing in numbers for a few days and then vanishing. This ephemerality, combined with the hygrophanous colour shifts, makes Psilocybe a difficult genus to document reliably and a dangerous one to approach casually.
Chemistry and potency
The active compounds are psilocybin and its dephosphorylated form psilocin, accompanied by smaller amounts of baeocystin, norbaeocystin, and, in some species, aeruginascin. Psilocybin itself is inactive until the body converts it to psilocin, which is the molecule that actually interacts with serotonin receptors in the brain. This is why the two names appear together throughout the literature.
Potency varies enormously, and this is one of the most important and least understood facts about the genus. Concentration differs between species, between populations of the same species, between individual fruiting bodies, and even within a single mushroom, with the caps generally richer than the stems. Environmental conditions, growth substrate, and drying method all shift the numbers. Reported values for the same species can differ several-fold across studies, which means any general statement about "how strong" a species is should be read as an approximate range rather than a fixed figure.
This variability is not a curiosity. It is the single biggest reason that dosing wild mushrooms is unpredictable, and it is why the genus is so difficult to study without cultivated, standardised material of the kind used in clinical research.
Safety and look-alikes
The central hazard is not Psilocybe itself but the mushrooms it resembles. Small brown mushrooms of grassland and dung are among the hardest to tell apart, and the group includes genera that carry deadly toxins. Some Galerina species, which can grow in the same habitats and share a broadly similar size and colour, contain the same amatoxins as the death cap and have caused fatal poisonings in people who mistook them for something harmless. A purple-brown spore print helps separate Psilocybe from a white-spored Galerina, but this is precisely the kind of detail that casual foragers miss.
Beyond misidentification, the effects of psilocybin themselves carry real risks for some people, including those with personal or family histories of psychotic illness. The point of a genus profile is documentary: to explain what these fungi are and why they matter, not to suggest that they are safe to seek out.
Where the science stands
Psilocybe is the best-characterised psilocybin genus, yet its taxonomy is still being rewritten. Molecular studies have reorganised species boundaries, moved members in and out of the genus, and shown that some long-used names cover several distinct biological species. The genus as currently defined is more coherent than it once was, but new species continue to be described, particularly from under-sampled regions in Latin America, Africa, and Asia.
The research picture is equally active. Because Psilocybe cubensis and a handful of relatives can be cultivated to yield standardised material, they underpin nearly all modern clinical work on psilocybin. That work has renewed scientific interest in the whole genus, including its chemistry, its evolution, and the question of why psilocybin arose in fungi at all. Psilocybe sits at the centre of that inquiry, the reference genus for a compound that has moved from ceremony to laboratory and back into public debate.
History and human context
No other genus in this index carries the human history that Psilocybe does. Species such as Psilocybe mexicana and Psilocybe cubensis were woven into the ritual life of Mesoamerican peoples long before European contact, used in healing and divinatory ceremonies that survived, often in secret, through centuries of colonial suppression. The wider world learned of these practices only in the mid-twentieth century, after which a Psilocybe species from Mexico became the source material for the first laboratory isolation of psilocybin, the moment the sacred mushroom became a named molecule.
From that point the genus moved rapidly into the modern era. Psilocybe cubensis proved unusually amenable to cultivation, and a body of home-growing technique built up around it that has no parallel among the other genera in this index, most of which cannot be cultivated at all. That cultivability is why cubensis, rather than a more potent wild species, became the workhorse of both informal use and formal research: it can be grown to yield consistent, identifiable, standardised material, which is precisely what science and safety both require.
The genus therefore spans the whole arc of the psilocybin story, from Indigenous ceremony to Life magazine to Sandoz laboratories to contemporary clinical trials for depression and end-of-life distress. When people speak loosely about "magic mushrooms" in any of these contexts, they are almost always speaking about Psilocybe, which is why it stands first in this index and why its history carries a weight the other genera do not.